Sort   by:  
 Page size 
0
Intellance-2: TruSight Tumor 170 panel based DNA-seq
0
Intellance-2: rRNA-minus RNA-seq
0
Intellance-2: TruSight Tumor 170 panel based RNA-seq
0
This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (...
0
Data Access Committee EGAC00001001818
Sort   by:  
 Page size